Please login to the form below
Harren Jhoti and Will West join BIA board
UK biotech trade body welcomes CEOs of Astex Pharmaceuticals and CellCentric
The UK's BioIndustry Association (BIA) has appointed Harren Jhoti, CEO of Astex Pharmaceuticals, and Will West, CEO of CellCentric, to its board of directors.
They take over from Andrew Heath, managing director of Morvus, and Dominique Kleyn, CEO of London Genetics, who will stand down at the end of 2012.
The BIA, which represents the country's bioscience industry, also re-appointed Allan Marchington, partner at Apposite Capital, to the board.
All appointments will serve from January 1, 2013, for a term of two years.
Tim Edwards, BIA chairman, said: “As a result of these appointments, I believe our board continues to broaden its outlook and experience, and I look forward to working with them and the BIA team to ensure the UK remains a world-leading location for the life sciences.”
Featured jobs
- Senior Brand Manager - Harlow
- Competitive
- Sales Manager - Media Publishing – Cheshire
- 25,000 to 35,000 per annum
- UK Marketing Director
- 80,000 to 100,000 per annum
- Group Account Director –Healthcare Advertising
- Neg
Subscribe to our email news alerts
- Achieving an aligned business intelligence capability - fact or fiction?
- Former Google chief launches online cancer forum
- Global biosimilars market to reach $2.45bn in 2013
- Value-based pricing "not in patient interest"
- Bringing trial data out of the shadows
- Novartis gets FDA green light for new Ilaris indication
- David Nicholson to step down as head of England’s NHS
- Roche repeats cancer drugs warning as Avastin faces another NICE rejection
- Italian pharma market set for continued downturn
- Novartis wins third NICE recommendation for Lucentis
- Health editor at The Sun newspaper joins Ruder Finn
- Informational source shift: from marketing to medical
PMHub
Add my companyLangland
We love what we do and we think it shows.It shows in the work we do, the space we ...
Latest intelligence
- How can pharma deliver returns on increased digital investment?
- Independent online professional networks work best as part of a multi-channel campaign ...
- The impact of Hollande's healthcare reforms in France
- A tougher environment for pharma, with market access and regulatory challenges...
- A guide to developing customer-centred, multichannel marketing
- Find out how a balanced approached to multichannel marketing could benefit your brand - the customer's agenda is just as important as Pharma's and needs to be listened to in ...
Quick links
